Medibio

Medibio Limited (MEB, formerly BioProspect Limited) is a medical technology company developing a new objective test to assist in the diagnosis of depression, other mental health disorders and chronic stress. This tests utilise circadian heart rate variability.

The technology is based on the scientific finding that circadian heart rate variability is a sensitive measure for depression and other mental health disorders and chronic stress

Contact Details

Level 4, 100 Albert Road , SOUTH MELBOURNE VIC 3205

03 9692 7222

info@medibio.com.au

www.medibio.com.au

Lists and Charts

Share price

Medibio
Closing price for the last 90 trading days

View ASX Chart

Revenue

Rank		Company	#
1012^th	-	Medibio	$963.76k

1332 public companies - non WA ranked by total revenue

View Full List

Company Share Transactions

Company Activity

	NEW ROLE: Matt Mesnik, Non-Executive Director	14 Mar 2022
	NEW ROLE: Stephen Mitchley, Non-Executive Director	22 Feb 2022
	NEW ROLE: S Sathre, Chief Financial Officer	25 Nov 2020
	NEW ROLE: R. E. Lees,	24 Nov 2020
	REMUNERATION UPDATE: Chris Indermaur, Non-Executive Chair	03 Nov 2020
	REMUNERATION UPDATE: Frank Prendergast, Non-Executive Director	03 Nov 2020
	REMUNERATION UPDATE: Peter Carlisle, Non-Executive Director	03 Nov 2020
	REMUNERATION UPDATE: David Kaysen, Chief Executive, Managing Director	03 Nov 2020
	REMUNERATION UPDATE: Michael Phelps, Non-Executive Director	03 Nov 2020

News Articles

Related Information

Access to our data for Medibio is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Medibio is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today